Barbara J. Shander advises public and private companies and private equity funds and their portfolio companies on mergers and acquisitions, dispositions, debt and equity financing transactions, corporate governance, and general corporate matters. Deputy manager of the firm’s private equity practice, Barb represents buyers and sellers in negotiated transactions involving privately held businesses, and subsidiaries and divisions of public companies. She also represents strategic and financial clients in structuring and negotiating mergers and acquisitions, equity financings, joint ventures, and commercial agreements.
Barb advises institutional investors on portfolio investments and buy-out transactions, as well as strategic and institutional clients on the issuance of debt and equity securities. She serves as outside general counsel to numerous companies, and advises them on a variety of commercial matters. Barb represents clients in several sectors including healthcare, energy, utilities, retail, technology, telecommunications, and manufacturing. Barb serves as a board member of the Philadelphia Chapter of the Association for Corporate Growth (ACG).
Represented Exelon Corporation in the sale of its interests in the Conemaugh and Keystone power plants to Arclight Capital Partners LLC.
Represented WIRB-Copernicus Group, a portfolio company of Arsenal Capital Partners, in its acquisitions of ePharmaSolutions, New England Independent Review Board and IRBNet.
Represented Creative Co-Op, a portfolio company of Eureka Growth Capital, in its acquisition of Bloomingville, a leading European designer and distributor of home lifestyle products.
Represented TractManager, Inc., a portfolio company of Arsenal Capital Partners, in its acquisition of MD Buyline.
Represented InnoPharma Inc. in its sale to Pfizer Inc.
Represented Sun Capital Partners in the sale of its affiliate, Cornerstone Research & Development Company, to Integrity Nutraceuticals, an affiliate of H.I.G. Capital.
Represented Acurian in its sale to Pharmaceutical Product Development LLC.
Represented Harry’s Fresh Foods, a portfolio company of Sun Capital Partners, in its sale to JGC Foods LLC, the food-focused subsidiary of Seattle-based Joshua Green Corporation.
Represented Dahlman Rose & Company, a research-driven privately held New York investment bank, in its sale to Cowen Group Inc.
Represented Eureka Growth Capital in the recapitalization, in partnership with management, of Creative Co-Op Inc. and affiliated companies.
Represented Exelon Corporation in the sale of three Maryland coal-fired power plants to Raven Power Holdings LLC, a new portfolio company of Riverstone Holdings LLC.
Represented Arsenal Capital Partners in its acquisitions of Western Institutional Review Board and Copernicus Group Institutional Review Board.
Represented Sun Capital Partners in its sale of Raybestos Powertrain to Monomoy Capital Partners.
Represented Galen Partners in its growth equity financing of Sharecare and HCPlexus, Inc., a portfolio company of Galen Partners, in its acquisition by Sharecare.
Represented NetBoss Technologies, a portfolio company of Eureka Growth Capital, in its acquisition of Sidonis Technologies, an emerging leader in service assurance.
Villanova University School of Law, 1995, J.D.
University of Delaware, 1992, B.S.
Awards and Affiliations
Recommended, M&A/Corporate and Commercial - Private Equity Buyouts, The Legal 500 US (2011–2017)
Former Board Member, Philadelphia Chapter of the Association for Corporate Growth
Former Board Member, The Wellness Community of Philadelphia